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Gastric cancer is one of the most epidemiologically significant cancers 
in the world. It is the fourth most common cancer, and second only 
to lung cancer as the leading cause of cancer deaths worldwide.[1] The 
incidence of gastric cancer varies in different regions of the world; the 
highest is in Japan and Korea.[2,3] In 2008, GLOBOCAN estimated the 
incidence in Eastern Asia at 42.4 per 100 000 per year in men and 18.3 
in women, and in Western Europe at round 8.6 and 4.2 respectively.[1] 
Accurate data on the incidence of most cancers in Africa are lacking 
and gastric cancer is no exception.[4] It has been estimated that the 
incidence is 5.6 and 4.0 per 100 000 per year in men and in women 
respectively in East Africa (the region that includes Zambia), and it 
was reported as the ninth leading cause of cancer mortality in Africa.[1]
Gastric cancer has been shown to be influenced by many 
factors, no single factor being identified as being causal,[5] though 
Helicobacter pylori infection is a dominant permissive factor. 
Lifestyle and environmental factors are implicated in the marked 
geographical variation of gastric cancer incidence.[4] Known risk 
factors for gastric cancer include infection with H. pylori, smoking, 
alcohol and diet.[4] The prevalence of H. pylori in the adult 
population of Lusaka is 81%[6] but there are no data on the 
interaction between H. pylori infection, lifestyle, gastric atrophy and 
other risk factors.
We previously observed that gastric cancer in Zambia seems to 
occur frequently in young adults7 but the reason for this is unclear. 
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Background. Gastric cancer is a leading cause of cancer deaths worldwide but there are few data from Africa. We recently observed a trend 
towards diagnosis in younger patients.
Objective. To test the hypothesis that HIV might have altered risk factors for acquisition of gastric cancer, in a case-control study in the 
University Teaching Hospital, Lusaka, Zambia.
Methods. Patients (n=52) with confirmed gastric adenocarcinoma and controls (n=94) undergoing endoscopy but with no macroscopic 
gastric pathology. Established risk factors and HIV status were compared.
Results. HIV status did not differ significantly between cases and controls (odds ratio 1.03; 95% CI 0.2 - 4.3; p=1.00) and seroprevalence 
in cases was similar to that of the Zambian population. Smoking, regular alcohol intake, and gastric atrophy were all associated with cancer 
in univariate and multivariate analysis. Helicobacter pylori serology was positive in 84% of patients studied and cytotoxin-associated gene A 
(cagA) serology in 66%; neither serological marker was associated with cancer. Atrophy was common in cases (57%) and controls (30%) and 
associated with both smoking and alcohol use. Intestinal metaplasia was present in 17% of the controls, but was not associated with atrophy.
Conclusions. HIV was not associated with gastric cancer and does not explain the apparent younger age distribution. Atrophy was common 
and was not essential for the development of intestinal metaplasia, suggesting that gastric carcinogenesis in Africa does not always follow 
the pathway from atrophy to intestinal metaplasia to gastric carcinoma (the so-called Correa pathway).
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A retrospective audit of endoscopy unit 
records at the University Teaching Hospital 
(UTH) in Lusaka, which is the largest 
referral hospital in Zambia, revealed that, 
in 1980 and 1982, all patients with gastric 
cancer were over the age of 50 years, but a 
5-year audit between 2002 and 2007,[7] and 
an audit in 2009 (Kayamba, unpublished 
observations), showed that the proportion 
of young patients with gastric cancer was 
20 - 25%. Changes in referral pattern or 
better endoscopic equipment, or alternative 
secular trends over the last 30 years, might 
explain this alarming observation; but there 
exists the possibility that it reflects exposure 
to a major biological health hazard. Since 
its recognition in Zambia in 1984, the HIV 
pandemic has had a major effect on public 
health, and has been causally related to 
malignancies such as lymphoma and Kaposi’s 
sarcoma. Notably, HIV predominantly 
affects adults in the age range 15 - 45 years.
We report on a case control study designed 
to investigate a possible association between 
gastric cancer and HIV infection. We also 
evaluated the presence of H. pylori infection, 
the virulence factor cytotoxin-associated 
gene A (cagA), and gastric atrophy measured 
by the pepsinogen 1 to 2 ratio and fasting 
gastrin-17 levels alongside other known risk 
factors for gastric cancer.
Methods
We carried out a prospective case-control 
study at UTH from November 2010 to January 
2012. Ethics approval was obtained from the 
Biomedical Research Ethics Committee of 
the University of Zambia (reference number 
008-02-10). Only adults 18 years or older 
presenting to the endoscopy unit were eligible 
for inclusion. Cases (n=52) were defined 
as patients with histopathologically proven 
adenocarcinoma, while controls (n=94) were 
patients with symptoms of dyspepsia but no 
mucosal abnormality seen at endoscopy. Two 
controls were selected for each case, and these 
were matched for sex; we attempted to achieve 
matching for age in the following age bands: 
<30 years, 31 - 45 years, 46 - 60 years and >60 
years. Patients who declined consent for an 
HIV test were excluded from the study, with all 
patients included giving written consent.
Endoscopic evaluation
Biopsies (≥6) were taken from any gastric 
lesion suspected to be malignant, and any 
adenocarcinoma was classified as diffuse, 
intestinal or of mixed type, according 
to the Lauren classification. In controls, 
duplicate biopsies were obtained from the 
antrum, body and cardia of the stomach 
and evaluated for inflammation (acute or 
chronic), atrophy and intestinal metaplasia. 
Biopsies were evaluated by an experienced 
pathologist (VM) and processed using 
haematoxylin/eosin and Giemsa stains 
and, where requested by the pathologist, 
periodic acid-Schiff (PAS). Five patients 
elected to take their biopsies to private 
histopathology services, and in 2 cases no 
Lauren classification was available.
Blood tests
Blood was collected to obtain serum which 
was then separated into aliquots and stored 
at -80oC until further analysis. For the H. 
pylori serology, pepsinogen 1 and 2 and 
gastrin-17 assays, Biohit Gastro Panel 
ELISA kits were obtained from Biohit 
(Helsinki, Finland), and for CagA, ELISA 
kits were obtained from Genesis Diagnostics 
(Cambridgeshire, UK) and used according 
to the manufacturer’s instructions. The 
presence of HIV infection was determined 
using Determine (Alere, Chiba, Japan) for 
screening and Unigold (Trinity Biotech, 
Wicklow, Ireland) for confirmation.
Data analysis
Data were anonymised and coded, then 
analysed using STATA 10.1 (Stata Corp, 
College Station, USA). For continuous 
variables showing a non-Gaussian 
distribution (i.e. all serological data), median 
and interquartile range is reported, and the 
Kruskal-Wallis test was used to compare 
the two groups; for categorical variables, 
Fisher’s exact test was used. Correlations 
were examined using Spearman’s rank 
correlation coefficient. An odds ratio (OR) 
with 95% confidence interval (CI) was 
used to express relative risk. A probability 
value <0.05 was considered statistically 
significant. For multivariate analysis, 
backwards stepwise unconditional logistic 
regression was used to assess the relative 
contributions of different exposure variables 
to the risk of gastric cancer. Conditional 
models were also assessed but, in view of 
the imperfect matching by age and the 
sparse data problem[9] consequent on having 
matching by 8 possible categories of age and 
sex, unconditional logistic regression was 
selected for the final model. In the end, both 
models gave very similar results.
Role of the funding source
The funding organisation had no role in 
the design and conduct of the study, in 
the collection, analysis and interpretation of 
the data, or in the preparation, review and 
approval of the manuscript.
Results
A total of 105 patients with suspected gastric 
cancer at endoscopy were initially enrolled. 
The suspicion was based on the presence of a 
gastric ulcer with raised edges or an obvious 
tumour mass. On histological analysis, 52 
had confirmed adenocarcinoma, 8 had 
gastric lymphoma, 2 Kaposi’s sarcoma (KS) 
and 1 malignant gastro-intestinal stromal 
tumour (Fig. 1). The remaining samples did 
not show any evidence of malignancy and 
were treated as benign gastric ulcers and 
followed up as such. For the analysis, only 
patients with confirmed adenocarcinoma 
were included. None of the patients with 
gastric cancer declined to give consent for 
participation in the study.
We were unable to recruit 2 controls 
contemporaneously for each case in 
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Fig. 1. Venn diagram of overlapping histological abnormalities in 90 controls. Most of the controls 
had chronic (active) inflammation, associated in some cases with intestinal metaplasia. Histological 
evidence of atrophy was seen in only 1 control, though serological markers suggested a 17% prevalence.
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the correct age band, largely owing to the small number of 
patients above the age of 60 years with normal findings at 
oesophagogastroduodenoscopy, but there was no statistically 
significant difference in the baseline characteristics between the 
cases and controls (Table 1). The average age among the cases 
was 60.6 years, and among the controls 54.1 years. Eleven (21%) 
of the gastric cancer patients were 45 years of age or younger. As 
expected, cases had significantly lower body mass index (BMI) 
and middle upper arm circumference (MUAC) than the controls 
(Table 1).
Histology revealed that up to 82% of the cancers were of the 
intestinal type, 17% were of the diffuse type, and 2% were mixed. 
Stratification by site showed that 62% of the cancers involved the 
antrum; of those that involved the cardia, the majority (6/10) were of 
the diffuse type. The mixed type of adenocarcinoma was only found 
in the antrum of 2 patients.
Table 1. Demographic and nutritional characteristics of cases and controls
Cases (n=52) Controls (n=94) p-value
Sex (M:F) 31:21 45:49 0.23
Age group, n (%) 0.056
≤30 years 2 (4) 4 (4)
31 - 45 years 9 (17) 26 (28)
46 - 60 years 9 (17) 28 (30)
≥61 years 32 (62) 36 (38)
Educational achievement, n (%) 0.37
None 10 (19) 10 (11)
Primary 17 (33) 34 (36)
Secondary or higher 25 (48) 50 (53)
Income, n (%) 0.18
<K1 million/month* 24 (75) 43 (60)
>K1 million/month   8 (25) 29 (40)
Nutritional status, median, (IQR)
BMI (kg/m2) 20.4 (17.1 -23.0) 23.9 (21.2 - 28.4) 0.0001
MUAC (cm) 25 (21 - 28) 28 (25 - 32) 0.0001
BMI = body mass index; MUAC = mid-upper arm circumference.
*K1 000 000 equates to US$200.








OR (95% CI) p-value OR (95% CI) p-value
Smoking
Ever smoked 14 (27) 7 (7) 4.6 (1.5 - 14.3) 0.002 3.4 (1.0 -11.4) 0.047
Current smoker 9 (17) 3 (3) 6.3 (1.5 - 37.8) 0.009 - -
Alcohol intake
 Ever consumed alcohol 
regularly?
21 (40) 17 (18) 3.1 (1.3 - 7.1) 0.005 2.8 (1.1 - 7.3) 0.03
 Currently consumer of 
alcohol?
12 (23) 9 (10) 2.8 (1.0 - 8.2) 0.046 - -
Family history 1 1 1.000
Serological evidence* of:
H. pylori infection 41/51 (79) 83/92 (88) 0.4 (0.1 - 1.3) 0.082 - -
CagA+ 31/46 (67) 26/82 (66) 1.0 (0.5 - 2.5) 1.000 - -
Low pepsinogen 1 7 (14) 7 (8) 1.8 (0.5 - 6.6) 0.381 - -
Low pepsinogen 1:2 ratio 29 (57) 26 (30) 3.0 (1.4 - 6.7) 0.004 3.8 (1.7 - 8.6) 0.002
Low gastrin-17 4/51 (8) 5.89 (7) 1.4 (0.3 - 7.0) 0.724 5.1 (1.1 - 7.3) 0.04
*Denominators as shown when data not available for all sera.
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HIV testing
In total, 4 (8%) cases and 7 (7%) controls were seropositive for HIV 
(OR 1.03, 95% CI 0.2 - 4.3; p=1.00). There was no association with 
HIV when only younger patients were analysed (2 of 11 cases ≤45 
years old and 3 of 30 controls; OR 2.0; 95% CI 0.1 - 20.3; p=0.60).
Lifestyle and serological risk factors in cases and controls
Some of the known risk factors of gastric cancer were also assessed 
in this patient population and compared between cases and controls 
(Table 2). Alcohol and cigarette smoking were found to increase the 
odds of developing gastric cancer in univariate and multivariate 
analysis. Low reported household income (dichotomised around 
K1 000 000 (US$200) per month) was not found to increase 
the odds of developing gastric cancer, though it approached 
significance (Table 1).
Serological markers of gastric cancer were also evaluated in these 
patients. The ratio of pepsinogen 1 to 2, a marker of gastric atrophy 
in the proximal stomach (fundus and corpus), was significantly lower 
in cases than the controls in both univariate and multivariate analysis 
(Table 2). The average age of the controls with low pepsinogen 1:2 
ratio was 55.5 years. Overall, 84% of all patients had antibodies to 
H. pylori infection (79% in cases, 88% in controls; p=0.08). Most 
patients had normal serum levels of serum gastrin-17, a marker of 
distal (antral) atrophy, and pepsinogen 1.
In multivariate analysis using unconditional logistic regression 
(Table 2), a statistically significant increase in risk was demonstrated 
in smokers, in patients with a history of ever having consumed 
alcohol on a regular basis, and in patients with markers of atrophy 
(low pepsinogen 1:2 ratio and low gastrin-17).
Precursor lesions in controls
None of the controls showed any evidence of dysplasia on histological 
analysis. Histologically, the prevalence of intestinal metaplasia in 
controls was found to be 17%, with over half of the controls having 
acute or chronic gastric inflammation (Table 3, Fig. 1). Only 2% of 
all the controls had histological evidence of gastric atrophy. Intestinal 
metaplasia was not restricted to patients with a background of gastric 
atrophy. Using low pepsinogen 1:2 ratio as a marker of atrophy, 6/14 
(43%) of patients with intestinal metaplasia did not have atrophy, 
and none of the patients with intestinal metaplasia had atrophy as 
assessed by low serum gastrin-17.
Serological markers of proximal gastric atrophy were also 
associated with lifestyle risk factors. Median (IQR) pepsinogen 1:2 
ratio was lower in current smokers (cases and controls combined, 
as few controls were smokers) than in non-smokers (1.96 (1.1 - 
3.5) v. 3.9 (2.3 - 6.3); p=0.02). Similarly, current alcohol drinkers 
had lower median (IQR) pepsinogen 1:2 ratios than non-drinkers 
(1.87 (1.2 - 4.1) v. 4.0 (2.4 - 6.3); p=0.01). No such differences were 
found in gastrin concentrations between smokers and drinkers. Low 
pepsinogen 1:2 ratio in controls was not correlated with H. pylori 
status (OR 1.33; 95% CI 0.22 - 14.4; p=1.0) though only 2 (8%) of 
the controls with evidence of atrophy were seronegative for H. pylori. 
This was also true for cagA (p=0.31); 27% of patients with atrophy 
were seronegative for cagA. We also checked for correlation among 
the serological parameters. Serum levels of pepsinogen 1 were found 
to correlate with pepsinogen 2 in controls (Spearman’s ρ=0.44, 
p<0.0001) but not cases (Spearman’s ρ=0.22, p=0.12). Conversely, 
an inverse correlation was found between serum gastrin-17 and 
pepsinogen 1:2 ratio in the cases (Spearman’s ρ=-0.29, p=0.038) 
but not controls (Spearman’s ρ=-0.02, p=0.84). We also calculated 
the ratio of gastrin-17:pepsinogen 2 as an alternative index of antral 
atrophy. Gastrin-17:pepsinogen 2 ratio was found to correlate with 
pepsinogen 1:2 ratio in controls (Spearman’s ρ=0.31, p=0.004) but 
not in cases (Spearman’s ρ=0.12, p=0.40).
Discussion
Gastric cancer is one of the most common causes of cancer-related 
mortality worldwide, yet data from Africa are very limited. [4,10] 
Our data do not support the hypothesis that gastric cancer is 
associated with HIV, which we had proposed to explain our clinical 
observations. In this study, 11 (21%) of 52 cases were <45 years of 
age, in contrast with 6.4% in the USA.[11] We do not believe that this 
is due merely to the difference in population age distribution.[7] Males 
also seem to be affected more than females in a ratio of 1.5:1, which is 
consistent with data from around the world. The male predominance 
held true in young patients (8:3), which suggests that in Africa, 
in contrast with industrialised countries, adenocarcinomas in the 
young are not dominated by diffuse cancers related to familial cancer 
syndromes. Indeed, 10/11 of these cancers in the young were of the 
intestinal type, and only one was diffuse. Smoking and alcohol intake 
appear to contribute to cancer risk, just as in other populations. 
H. pylori infection is common in cases and controls alike, and appears 
to be slightly less common in cases, which we surmise may be due to 
reduced colonisation in the achlorhydric stomach during malignant 
transformation. Ingestion of acid suppressants to relieve symptoms 
is another possibility. Most of the cases of adenocarcinoma were 
found to be associated with gastric atrophy as evidenced by the low 
pepsinogen 1:2 ratios, and to be of the intestinal type that is more 
influenced by environmental factors.
Our data seem to confirm that cancer in young adults is a 
significant proportion of the overall burden, consistent with data 
from South Africa.[12] We found no suggestion that HIV explains these 
gastric cancers in the young adult. The overall prevalence of HIV 
infection found in this study was lower than the national prevalence 
of 14%.[13] This can be explained by the fact that the average age of 
the patients enrolled was 60.6 years and, in Zambia, the prevalence 









Intestinal metaplasia 1 0 14 15 (17)
Atrophy 1 0 1 2 (2)
Acute inflammation 4 3 3 5 (5)
Chronic active inflammation 23 16 6 24 (26)
Chronic inflammation 26 14 10 29 (32)
Normal histology 37 57 71 34 (37)
*Some of these patients had combined lesions; consequently, the percentages do not total 100.
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of HIV infection in that age group is much lower than 14%. In the 
present study, the proportion of HIV infection among young patients 
(<45 years) is similar to the prevalence recorded in the Zambian 
demographic and health survey of 2007,[13] in which the prevalence 
of HIV infection in the 18 - 45 age group varied between 12% and 
26% across the country. If HIV were the dominant explanation of the 
changing epidemiology of gastric cancer in Zambia, the proportion 
of patients with the infection would have been significantly higher 
among the cases.
Smoking and alcohol intake were found to be strongly associated 
with gastric cancer in both univariate and multivariate analysis, and 
associated with gastric atrophy in the controls. Information was 
obtained on which patients were still smoking or taking alcohol at 
the time of enrolment and which patients had stopped. However, 
the type or the duration of exposure to these risk factors was not 
evaluated. Cigarettes in Zambia are often made by the consumer 
and of variable (often formidable) strength; and alcohol is consumed 
as either home-brewed millet beer or home-distilled maize spirit. 
Consequently, exposure is difficult to quantify and, while current 
tobacco intake could be estimated from cotinine concentrations, 
this does not indicate past exposure. Such biomarker measurements 
would also be of limited value owing to behaviour modification as a 
result of ill-health.
H. pylori is a known carcinogen and may explain two-thirds of 
all gastric cancers worldwide.[14] Its prevalence in Zambia is known 
to be high[6] and, if the only factor at play, the incidence of gastric 
cancer might also be expected to be high. We found no significant 
difference in H. pylori seroprevalence between the cases and the 
controls, but in a case-control study we cannot obtain information 
on duration or intensity of exposure. As H. pylori infection is 
related to socio-economic and housing conditions, it is probable 
that intensity of exposure is high. A relationship between infection 
and cancer is further obscured when the risk factor is so common 
in the control group and when the onset of disease is likely to affect 
intensity of bacterial colonisation (through hypochlorhydria) and 
therefore the sensitivity of the diagnostic test.[15-17] The H. pylori 
virulence factor cagA likewise did not differ in cases and controls, 
which is consistent with other studies in high-prevalence areas. [18] 
The prevalence of intestinal metaplasia in healthy people in 
African studies varies from 4% to 28%;[4] our data fall into the 
middle of this range.
In a setting dominated by intestinal-type cancers, as in Zambia, 
gastric atrophy is an important precursor lesion leading to intestinal 
metaplasia and then cancer as suggested by Correa et al.[19] Atrophy, 
as assessed by serum pepsinogen 1:2 ratio,[20] was strongly associated 
with cancer, which is consistent with previous work. This was not 
true of low gastrin-17, which largely reflects antral atrophy. In a 
recent review, we found the prevalence of atrophy to be high (25% or 
more) in 5 out of 9 studies from Africa,[4] and our serological data are 
consistent with a high prevalence of atrophy compared with 12% in 
Finland[21] and 27.6% in Japan.[22] We found no evidence that atrophy 
is more prevalent in patients with the intestinal type of gastric cancer, 
which differs from recent work in Germany.[19] Our data suggest that 
intestinal metaplasia can occur independently of gastric atrophy, 
whether assessed histologically or serologically. If this suggestion is 
confirmed by other studies in Africa that use multiple measures of 
atrophy simultaneously, the Correa model of gastric carcinogenesis 
may require further refinement.
Our study has clearly demonstrated the need for more work on 
gastric cancer in Africa, as the reasons for early onset of the cancer 
have not been established.
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